DEVELPOMENT AND EVALUATION OF SUSTAINED RELEASE FORMULATIONS OF VENLAFAXINE HYDROCHLORIDE 

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 5

Abstract

In the present study, Venlafaxine was chosen as a model drug which is a Anti-Depressant. Because of its short life (5-11hr) and its high water solubility it was chosen as a suitable candidate for sustain matrix tablet formulation. It was formulated in to matrix tablet using hydrophilic polymer such as HPMC, Eudragit RS100, and Ethyl cellulose as releases retardants. All the precompressional parameters were found to be within the standard limits. Tablets were evaluated for hardness, friability, thickness, drug content, in-Vitro release, swelling and stability studies. The effect of polymer concentration binary polymer mixture and wet granulation method on drug release profile was studied. It was absorbed that the type of polymer and its concentration has influence the drug release from matrix tablet. Matrix tablet content a blend of HPMC and ethyl cellulose successfully sustained the release of Venlafaxine for a period of 17hr. Precompressional parameter indicated that granules used for preparing tablets with free flowing. Post-copmressional parameters were within the acceptable limit. The concentration of Venlafaxine was kept constant, lactose used as filler. The sustained release from ethyl cellulose and HPMC was due to interaction between ethylcellulose chain ionic polymer and HPMC chain, non-ionic polymer, which resulted in favorable increase in the water uptake capacity and gel viscosity, leading to better control over the release of Venlafaxine F4 showed the sustained release of Venlafaxine as desired. The study revealed that the ethyl cellulose and HPMC can be used for the formulation of sustained release matrix tablet of Venlafaxine.  

Authors and Affiliations

Sreenivasa rao, Sunita Jadhav , Prakash Patil , B. U. Dattatraya

Keywords

Related Articles

NEW INSIGHTS INTO MOLECULAR TARGETS FOR DEPRESSION 

Major depressive disorder is a heritable neuropsychiatric syndrome characterized by relatively subtle cellular and molecular alterations localized to a complex network of neural substrates. Various forms of psychotherapy...

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD IN MULTI-COMPONENT FORMULATION 

The aim of the present work was focused on development of an analytical method for simultaneous estimation of drugs in multi-component dosage form by using RP-HPLC. Chromatographic separation techniques are one of the mo...

REVIEW ON CASEIN PRODUCTION AND CASEIN BASED NANO-FORMULATIONS 

Biodegradable systems have the ability to release the drug for a prolonged period of time and subsequently degrade which can be easily cleared from the body. This property makes use of them for the design of carriers for...

ANALYSIS OF PRESCRIPTION PATTERN AND DRUG UTILIZATION IN ASTHMA THERAPY  

This drug utilization or prescription-monitoring study was conducted to evaluate the drug-prescribing trend of anti-asthmatic drugs in retailed pharmacy outlets during 2009 and 2011 in urban and rural area of Saurashtra...

PHARMACOGNOSY AND PHYTOCHEMICAL EVALUATION OF ROOTS OF ECHINOPS ECHINATUS ROXB.  

The genus Echinops echinatus Roxb. belongs to family Asteraceae found in India. Commonly known Kantaphala as in Sanskrit Roots used as medicine. It is used in dyspepsia, scrofula, syphilis and fever. It is also advised t...

Download PDF file
  • EP ID EP150666
  • DOI -
  • Views 110
  • Downloads 0

How To Cite

Sreenivasa rao, Sunita Jadhav, Prakash Patil, B. U. Dattatraya (2011). DEVELPOMENT AND EVALUATION OF SUSTAINED RELEASE FORMULATIONS OF VENLAFAXINE HYDROCHLORIDE . International Research Journal of Pharmacy (IRJP), 2(5), 261-270. https://europub.co.uk/articles/-A-150666